Geisinger Health System in Danville, Pa., will collaborate with Regeneron Pharmaceuticals in a major research project to identity genetic determinants of human disease.

Geisinger brings a patient base of three million, its substantial information technology capabilities including an enterprise electronic health records system, and its MyCode bio repository of blood samples from about 45,000 consenting patients.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access